UOC
CLOV icon

UBS O'Connor’s Clover Health Investments CLOV Stock Holding History

UBS O'Connor’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-937,162
Closed -$3.6M – 598
2020
Q3 		$3.6M Sell
937,162
-12,838
-1% -$142K 0.09% 138
2020
Q2 		$2.83M Buy
+950,000
New +$10.2M 0.06% 201

Other funds holding CLOV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS O'Connor's CLOV Position: Q1 2022 in Review

UBS O'Connor sold out of Clover Health Investments (CLOV) in Q1 2022, closing a stake of 2,180,000 shares — an estimated $8.11M sold.

UBS O'Connor first reported a position in CLOV in Q2 2020 and held it in 3 quarters. The position peaked at $31.9M in Q2 2020. 168 funds tracked by Wall St. Rank hold CLOV as of Q1 2022.

  • UBS O'Connor reported no remaining Clover Health Investments position as of Q1 2022 after selling out during the quarter.
  • UBS O'Connor sold 2,180,000 Clover Health Investments shares in Q1 2022, an estimated $8.11M.
  • UBS O'Connor first reported a position in Clover Health Investments in Q2 2020 and held it in 3 quarters.
  • UBS O'Connor's Clover Health Investments position peaked at $31.9M in Q2 2020.
  • 168 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2022.

Based on UBS O'Connor's 13F filing for Q1 2022, filed 16 May 2022.